Physician profile
Daniel L Rothbaum
NPI 1134168438
$741.20
in general payments reported to CMS, 2019-2025
13 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $15.69 · 2021: $62.81 · 2022: $76.67 · 2023: $20.04 · 2024: $19.17 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $247 · Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $247.17 |
| Food and Beverage | $200.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $408.46 | 2025 | Inspire |
| Stryker Corporation | $84.15 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $60.78 | 2019-2021 | |
| Medtronic, INC. | $23.76 | 2022 | |
| Acclarent, INC | $23.29 | 2019 | |
| Intersect Ent, INC. | $23.28 | 2019 | |
| Smith+Nephew, INC. | $23.14 | 2019 | |
| Glaxosmithkline, LLC. | $20.04 | 2023 | Nucala |
| Pentax of America, INC. | $19.17 | 2024 | Pentax Medical, C2 Cryoballoon, C2 Cryoballoon Focal Controller |
| Kaleo, INC. | $15.69 | 2020 | |
| Optinose US, INC. | $14.25 | 2019 | |
| Phadia US INC. | $13.37 | 2019 | |
| Alk-Abello, INC | $11.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Rothbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.